Keyphrases
Pancreatic Cancer
100%
Transforming Growth Factor-β
100%
Murine Model
100%
Tumor Microenvironment
100%
Vaccine Target
100%
Immune Modulatory Vaccine
100%
Derived Peptide
66%
Pancreatic Ductal Adenocarcinoma
55%
Immunosuppression
33%
Pan02
33%
Gene Expression
22%
Tumor
22%
Tumor Growth
22%
Fibrosis
22%
Peptide Vaccine
22%
MHC Class II
22%
Immune Infiltration
22%
Immune-related Genes
22%
Gene Expression Profile
11%
Quantitative PCR
11%
Flow Cytometry
11%
Immune Response
11%
Fibroblasts
11%
Collagen
11%
Immune Activation
11%
Enlargement
11%
Cancer Mortality
11%
Infiltration
11%
T Cells
11%
Vaccination
11%
CD8+ T Cells
11%
Antitumor Activity
11%
C57BL
11%
Specific T Cells
11%
TGF-1
11%
Myofibroblast
11%
Tumor Samples
11%
Tumor-draining Lymph Nodes
11%
European Union
11%
Therapeutic Effect
11%
ELISPOT
11%
Poor Survival
11%
Immunogenic
11%
All Cancer
11%
Adjuvanted
11%
Tumor-bearing Mice
11%
Cancer-associated Fibroblasts
11%
Montanide
11%
Desmoplastic
11%
Pancreatic Duct Cells
11%
Immunotherapeutic Approaches
11%
Peptide Vaccination
11%
Cellular Composition
11%
M2 Macrophages
11%
PMHC
11%
Pro-inflammatory Phenotype
11%
Murine Tumor Model
11%
Tumor Conditioned Medium
11%
Bulk RNA Sequencing
11%
Immunology and Microbiology
Vaccine Efficacy
100%
Immunosuppressive Drug
100%
Transforming Growth Factor
100%
Mouse
55%
Immunosuppression
33%
Gene Expression
22%
Major Histocompatibility Complex
22%
T Cell
22%
Vaccination Policy
22%
Immune Cell Infiltration
22%
Peptide Vaccine
22%
Immune Response
11%
Fibroblast
11%
Lymph Node
11%
Cytotoxic T-Cell
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Immunotherapy
11%
Myofibroblast
11%
Volume
11%
C57BL 6 Mouse
11%
Antineoplastic Activity
11%
RNA Sequence
11%
Cancer Associated Fibroblast
11%
M2 Macrophages
11%